- Research works
- 96 ▲ 84% vs 2013–17
- Citations
- 991 10.4 per fractional work
- Top-10% rate
- 17.3% record average 16.5%
- Open access
- 63% world 28%
Not ranked overall: Quantify Research (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 8.9×. Every wedge is a field page.
- Economics, Econometrics and Finance 8.9×
- Immunology and Microbiology 3.6×
- Health Professions 3.3×
- Medicine 2.8×
- Decision Sciences 2.5×
- Mathematics 1.1×
- Neuroscience 0.9×
- Psychology 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Environmental Science 0.4×
- Biochemistry, Genetics and Molecular Biology 0.2×
- Agricultural and Biological Sciences 0.2×
- Nursing 0.2×
- Engineering 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
Who are the top researchers at Quantify Research (Sweden)?
Ranked on the composite score, Fredrik Borgström lead among researchers whose main affiliation is Quantify Research (Sweden).
- 1 Fredrik Borgström Sweden · #475,652 worldwide 85 citations · 19 works
Which keywords describe research at Quantify Research (Sweden)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Clinical Practice Guidelines, Clinical Trials, Pharmaceutical Industry and Drug Development Costs.
- Reproducibility
- Pneumococcal Conjugate Vaccine
- Health Care
- Community-Acquired Pneumonia
- Uterine Leiomyoma
- Spondyloarthritis
- Health-related Quality of Life
- Social Determinants
- Chronic Disease
- Metabolic Syndrome
- Autoantibodies
- Mental Health
- Generic Drugs
- Pharmaceutical Industry
- Clinical Trials
- Health Utility Measures
- Quality of Life
- Epidemiology
- Cost-effectiveness Analysis
- Inflammation
- Clinical Practice Guidelines
- Drug Development Costs
- Biomarkers
- Public Health
- Immune System
- Primary Care
- Health Outcomes
- Ankylosing Spondylitis
- Neuroimaging
- Uterine Fibroids
- Cardiovascular Risk
- Food Insecurity
- Nutritional Consequences
- Regulatory T Cells
- Scientific Workflows
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Epidemiology7▲ 4.3×26 topics
- Quality of Life7▲ 11×9 topics
- Cost-effectiveness Analysis6▲ 159×1 topic
- Health Utility Measures6▲ 159×1 topic
- Inflammation2▲ 2.5×11 topics
- Clinical Trials2▲ 6.7×6 topics
- Clinical Practice Guidelines2▲ 7.9×6 topics
- Pharmaceutical Industry2▲ 107×2 topics
- Drug Development Costs2▲ 147×1 topic
- Generic Drugs2▲ 147×1 topic
- Biomarkers2▲ 5.3×4 topics
- Mental Health2▲ 2.5×2 topics
- Public Health2▲ 2.4×6 topics
- Autoantibodies1▲ 13×3 topics
- Immune System1▲ 13×3 topics
- Metabolic Syndrome1▲ 3.7×6 topics
- Primary Care1▲ 8.0×5 topics
- Chronic Disease1▲ 16×3 topics
- Health Outcomes1▲ 10×4 topics
- Social Determinants1▲ 13×2 topics
- Ankylosing Spondylitis1▲ 94×1 topic
- Health-related Quality of Life1▲ 11×2 topics
- Neuroimaging1▲ 9.3×5 topics
- Spondyloarthritis1▲ 94×1 topic
- Uterine Fibroids1▲ 87×1 topic
- Uterine Leiomyoma1▲ 87×1 topic
- Cardiovascular Risk1▲ 7.8×3 topics
- Community-Acquired Pneumonia1▲ 73×1 topic
- Food Insecurity1▲ 40×1 topic
- Health Care1▲ 25×2 topics
- Nutritional Consequences1▲ 49×1 topic
- Pneumococcal Conjugate Vaccine1▲ 73×1 topic
- Regulatory T Cells1▲ 21×2 topics
- Reproducibility1▲ 69×1 topic
- Scientific Workflows1▲ 69×1 topic
Which research topics does Quantify Research (Sweden) publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Uterine Myomas and Treatments and Spondyloarthritis Studies and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 6 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
- 3 Uterine Myomas and Treatments Obstetrics and Gynecology 1 works
- 4 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 5 Psoriasis: Treatment and Pathogenesis Immunology 1 works
- 6 Food Security and Health in Diverse Populations General Health Professions 1 works
- 7 Scientific Computing and Data Management Information Systems and Management 1 works
- 8 Pneumonia and Respiratory Infections Epidemiology 1 works
- 9 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 10 Healthcare cost, quality, practices General Health Professions 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Quantify Research (Sweden)'s research output changed?
Output in 2018–2022 was 84% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Stockholm
- Karolinska Institutet
- KTH Royal Institute of Technology
- Stockholm University
- Karolinska University Hospital
- Swedish Institute
- Stockholm School of Economics
- Science for Life Laboratory
- Swedish Defence Research Agency
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.